EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Mechanisms of Resistance and Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: A Narrative Review

Jin Li, Jin-Yi Zhou, Yue Yu, Xing-Ming Chen, Wan-Ling Luo iD, Yawhan Lakang, Jin-Xiang Zuo iD, Zi-Sheng Yang, Hao-Bo Xu, Yu-Bo Liang iD, Qing-Bo Wang iD, Yu-Kai Li und 2 weitere

Journal of Hepatocellular Carcinoma · 2026-10 · Volume 13 · 1-29

DOI: 10.2147/jhc.s622555 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Hepatocellular Carcinoma, 2026-10. Verfasst von Jin Li und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, People's Republic of China. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

adverse eventsimmune checkpoint blockadeimmunotherapyliver cancermechanismrefractoriness

Autor:innen und Institutionen

  • Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, People's Republic of China.
  • The Second Clinical Medical College, Kunming Medical University, Kunming, Yunnan, People's Republic of China.
  • Department of Bone and Joint Surgery, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.
  • Department of Hepatobiliary Surgery and Liver Transplantation, The First People's Hospital of Yunnan Province, Kunming, Yunnan, People's Republic of China.
  • Department of International Healthcare, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, People's Republic of China.
  • Department of Hepatobiliary Surgery, Beihai People's Hospital, Beihai, Guangxi, People's Republic of China.

ORCID-Profile: Wan-Ling Luo, Jin-Xiang Zuo, Yu-Bo Liang, Qing-Bo Wang, Yang Ke

Zitieren

APA

Li, J., Zhou, J. Y., Yu, Y., Chen, X. M., Luo, W. L., Lakang, Y., Zuo, J. X., Yang, Z. S., Xu, H. B., Liang, Y. B., Wang, Q. B., Li, Y. K., Shang, L. M., & Ke, Y. (2026). Mechanisms of Resistance and Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: A Narrative Review. Journal of Hepatocellular Carcinoma, Volume 13, 1-29. https://doi.org/10.2147/jhc.s622555

Vancouver

Li J, Zhou JY, Yu Y, Chen XM, Luo WL, Lakang Y, et al. Mechanisms of Resistance and Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: A Narrative Review. Journal of Hepatocellular Carcinoma. 2026;Volume 13:1-29. doi:10.2147/jhc.s622555

BibTeX
@article{Li2026,
  author = {Li, Jin and Zhou, Jin-Yi and Yu, Yue and Chen, Xing-Ming and Luo, Wan-Ling and Lakang, Yawhan and Zuo, Jin-Xiang and Yang, Zi-Sheng and Xu, Hao-Bo and Liang, Yu-Bo and Wang, Qing-Bo and Li, Yu-Kai and Shang, Li-Ming and Ke, Yang},
  title = {Mechanisms of Resistance and Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: A Narrative Review},
  journal = {Journal of Hepatocellular Carcinoma},
  year = {2026},
  volume = {Volume 13},
  pages = {1--29},
  doi = {10.2147/jhc.s622555}
}
Kostenlos starten →